Bristol-Myers Squibb Company
Patents, Design & Utilities
Last updated:
List of all Bristol-Myers Squibb Company patents 772 in total
| Status | Patent |
|---|---|
Application | Utility: 2-(1,1'-BIPHENYL)-1H-BENZODIMIDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS APELIN AND APJ AGONISTS FOR TREATING CARDIOVASCULAR DISEASES Filling date: 6 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 23 Jul 2020 |
Grant | Utility: Pyrrolidine GPR40 modulators Filling date: 6 Sep 2025 Issue date: 21 Jul 2020 |
Grant | Utility: Pyrrole amides as alpha V integrin inhibitors Filling date: 6 Sep 2025 Issue date: 21 Jul 2020 |
Grant | Utility: Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists Filling date: 6 Sep 2025 Issue date: 21 Jul 2020 |
Application | Utility: CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS Filling date: 6 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: PROCESS FOR THE PREPARATION OF N-((1R,2S,5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO[1,5-A][1- ,3,5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE Filling date: 6 Sep 2025 Issue date: 16 Jul 2020 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Tricyclic sulfones as ROR.gamma. modulators Filling date: 6 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Substituted bicyclic compounds Filling date: 6 Sep 2025 Issue date: 14 Jul 2020 |
Application | Utility: METHODS OF TREATING AUTOIMMUNE DISEASE USING A DOMAIN ANTIBODY DIRECTED AGAINST CD40L Filling date: 6 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: IMMUNOMODULATORS Filling date: 6 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS Filling date: 6 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: PIPERIDINONE FORMYL PEPTIDE 2 RECEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 2 Jul 2020 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Aryl dihydropyridinones and piperidinone MGAT2 inhibitors Filling date: 6 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Spirolactams as inhibitors of ROCK Filling date: 6 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Use of alkaline washes during chromatography to remove impurities Filling date: 6 Sep 2025 Issue date: 30 Jun 2020 |
Application | Utility: METHODS OF TREATING IMMUNE DISEASES BY ADMINISTERING ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40 Filling date: 6 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTIBODY Filling date: 6 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: ANTI-NKG2A ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: SUPRAMOLECULAR FILAMENTOUS ASSEMBLIES FOR PROTEIN PURIFICATION Filling date: 6 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: CYCLOPROPYL UREA FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 25 Jun 2020 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 23 Jun 2020 |
Grant | Utility: Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer Filling date: 6 Sep 2025 Issue date: 23 Jun 2020 |
Grant | Utility: IDO inhibitors Filling date: 6 Sep 2025 Issue date: 23 Jun 2020 |
Grant | Utility: Anti-GITR antibodies for cancer diagnostics Filling date: 6 Sep 2025 Issue date: 23 Jun 2020 |
Application | Utility: IP-10 ANTIBODIES AND THEIR USES Filling date: 6 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR Filling date: 6 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: ANTIBODIES AGAINST TIM3 AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 18 Jun 2020 |
Grant | Utility: Antibodies against OX40 and uses thereof Filling date: 6 Sep 2025 Issue date: 16 Jun 2020 |
Grant | Utility: Tricyclic compounds as anticancer agents Filling date: 6 Sep 2025 Issue date: 16 Jun 2020 |
Application | Utility: IMPROVED METHODS OF ANTIBODY PRODUCTION THAT MINIMIZE DISULFIDE BOND REDUCTION Filling date: 6 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: SUBSTITUTED ISOQUIONLINE DERIVATIVES AS IMMUNOMUDULATORS Filling date: 6 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: PYRIMIDINE CARBOXAMIDES AS GSK-3 INHIBITORS Filling date: 6 Sep 2025 Issue date: 11 Jun 2020 |
Grant | Utility: Carbazole derivatives Filling date: 6 Sep 2025 Issue date: 9 Jun 2020 |
Grant | Utility: Phenylpyrrolidinone formyl peptide 2 receptor agonists Filling date: 6 Sep 2025 Issue date: 9 Jun 2020 |
Grant | Utility: Quinazolines as potassium ion channel inhibitors Filling date: 6 Sep 2025 Issue date: 9 Jun 2020 |
Grant | Utility: Factor XIa macrocycle inhibitors bearing a non-aromatic P2' group Filling date: 6 Sep 2025 Issue date: 9 Jun 2020 |
Grant | Utility: Antibodies conjugatable by transglutaminase and conjugates made therefrom Filling date: 6 Sep 2025 Issue date: 9 Jun 2020 |
Application | Utility: USE OF PHENOLIC ANTIOXIDANTS IN CELL BIOPRODUCTION Filling date: 6 Sep 2025 Issue date: 4 Jun 2020 |
Application | Utility: IMMUNOMODULATORS ACTING AS ANTAGONISTS OF PD-1 Filling date: 6 Sep 2025 Issue date: 4 Jun 2020 |
Grant | Utility: Substituted naphthyridinone compounds useful as T cell activators Filling date: 6 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: 3-sulfonyl-5-aminopyridine-2,4-diol APJ agonists Filling date: 6 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: Heteroarylhydroxypyrimidinones as agonists of the APJ receptor Filling date: 6 Sep 2025 Issue date: 2 Jun 2020 |
Application | Utility: SELECTIVE NR2B ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: INDOLE CARBOXAMIDE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: FIVE MEMBERED-AMINOHETEROCYCLE AND 5,6-or 6,6-MEMBERED BICYCLIC AMINOHETEROCYCLIC INHIBITORS OF ROCK FOR THE TREATMENT OF HEART FAILURE Filling date: 6 Sep 2025 Issue date: 28 May 2020 |
Grant | Utility: Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists Filling date: 6 Sep 2025 Issue date: 26 May 2020 |
Showing 500 to 550 of 772 patents.